Clinical Trial Update: Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating lymphatic mapping in patients with stage I or stage II vulvar cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvar Cancer

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Vulvar Cancer | Phase 3 | Status: COMPLETED